Treace Medical Concepts (TMCI) - רווח נקי למניה (EPS TTM)

Net income per share over the last four quarters demonstrates capital management efficiency, where -0.86 shows the current value of the metric for Treace Medical Concepts (TMCI). Cash flow remains stable due to the implementation of foot correction systems. Patent protection of a narrow niche ensures high margins. However, expansion by large orthopedic behemoths creates risks of market share loss.

The aggressive scaling of Treace Medical Concepts (TMCI) through surgeon training and the capture of the foot correction market requires strict control over capital efficiency. By analyzing the rolling earnings per share trend, an investor assesses the final financial result adjusted for share dilution, which allows for the verification of the issuer's actual margin of safety and eliminates the risk of inflating business value through leverage.